People · Operator

Esteban H. Cvitkovic, M.D.

Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals

1
Companies
1
Filings
$39.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Access Pharmaceuticals IncPharmaceuticalsSeries A$39.2M$423.2M2011
Operator network

Esteban H. Cvitkovic, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Mark J Ahn · 3 companies · 1 sharedMark J AhnJeffrey B. Davis · 2 companies · 1 sharedJeffrey B. DavisTodd B. Wider · 2 companies · 1 sharedTodd B. WiderJeffrey H. Davis · 1 companies · 1 sharedJeffrey H. DavisMark J. Ahn, Ph.D. · 1 companies · 1 sharedMark J. Ahn, Ph.D.Mark J. Alvino · 1 companies · 1 sharedMark J. AlvinoStephen B. Howell · 1 companies · 1 sharedStephen B. HowellStephen B. Howell, M.D. · 1 companies · 1 sharedStephen B. Howell…Stephen B. Thompson · 1 companies · 1 sharedStephen B. Thomps…Steven H. Rouhandeh · 1 companies · 1 sharedSteven H. Rouhand…Tim B. Miller · 1 companies · 1 sharedTim B. MillerTodd B. Widder · 1 companies · 1 sharedTodd B. WidderAccess Pharmaceuticals Inc · $39.2M raisedAccess Pharmaceutical…Esteban H. Cvitkovic, M.D.EM
Esteban H. Cvitkovic, M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Esteban H. Cvitkovic, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Mark J Ahn13
Jeffrey B. Davis12
Todd B. Wider12
Jeffrey H. Davis11
Steven H. Rouhandeh11
Mark J. Alvino11
Stephen B. Thompson11
Todd B. Widder11
Stephen B. Howell11
Tim B. Miller11
Stephen B. Howell, M.D.11
Mark J. Ahn, Ph.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.